Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia

Journal of Clinical Immunology

Volumn 22, Issue 4, 2002, Pages 244-251

  Brunner, Cornelia ^a   Kreth, Hans Wolfgang ^a   Ochs, Hans D ^b   Schuster, Volker ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Btk; CD40; EBV; JNK; XLA

Indexed keywords

BURTON TYROSINE KINASE; CD40 ANTIGEN; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; AGAMMAGLOBULINAEMIA TYROSINE KINASE; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; MATRIX PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1;

ARTICLE; CELL SUBPOPULATION; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; X LINKED AGAMMAGLOBULINEMIA; AGAMMAGLOBULINEMIA; ANIMAL; B LYMPHOCYTE; CELL LINE; ENZYMOLOGY; GENETIC LINKAGE; GENETICS; IMMUNOLOGY; IN VITRO STUDY; METABOLISM; MOUSE; MUTATION; VIRUS CELL TRANSFORMATION; X CHROMOSOME;

AGAMMAGLOBULINEMIA; ANIMALS; ANTIGENS, CD40; B-LYMPHOCYTES; CELL LINE; CELL TRANSFORMATION, VIRAL; CHROMOSOMES, HUMAN, X; ENZYME ACTIVATION; HERPESVIRUS 4, HUMAN; HUMANS; LINKAGE (GENETICS); MICE; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; VIRAL MATRIX PROTEINS;

EID: 0035996806     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016097010274     Document Type: Article

References (40)

1. B cells in patients with X-linked agammaglobulinemia
2. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia
3. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases
4. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia
5. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages
6. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells
7. Genetic defect in human X-linked agammaglobulinemia impedes a maturational evolution of pro-B cells into a later stage of pre-B cells in B-cell differentiation pathway
8. BTKbase, mutation database for X-linked agammaglobulinemia (XLA)
9. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 Unique mutations without correlation to clinical course
10. Discordant phenotype in siblings with X-linked agammaglobulinemia
11. Extreme variation in X-linked agammaglobulinemia phenotype in a three-generation family
12. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice
13. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency gene
14. The CBA/N mouse strain: An experimental model illustrating the influence of the X-chromosome on immunity
15. Btk function in B cell development and response
16. B cells from CBA/N mice do not proliferate following ligation of CD40
17. Defective B cell development and function in Btk-deficient mice
18. Induction of costimulatory molecules B7-1 and B7-2 in murine B cells. The CBA/N mouse reveals a role for Bruton's tyrosine kinase in CD40-mediated induction
19. Bruton's tyrosine kinase is present in normal platelets and its absence identified patients with X-linked agammaglobulinemia and carrier females
20. Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia
21. Selective activation of c-Jun kinase mitogen-activated protein kinase by CD40 on human B cells
22. Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases
23. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor
24. Bruton's tyrosone kinase regulates apoptosis and JNK/SAPK kinase activity
25. Bruton's tyrosine kinase-mediated interleukin-2 gene activation in mast cells dependence on the c-Jun N-terminal kinase activation pathway
26. Different protein kinases are required for B cell antigen receptor-mediated activation of extracellular signal regulated kinases, c-Jun NH2-terminal kinase 1, and p38 mitogen activated protein kinase
27. Involvement of Ras in Bruton's tyrosine kinase-mediated JNK activation
28. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family
29. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: Role in NF-kappaB activation
30. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein
31. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1)
32. A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated protein kinase
33. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor
34. Down-regulation of the EBV-encoded membrane protein (LMP) in Burkitt lymphomas
35. The EBV transforming protein, LMP1, mimics and cooperates with CD40 signaling in B lymphocytes
36. Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1)
37. Profound reduction of mature B cell numbers, reactivities and serum Ig levels in mice which simultaneously carry the XID and CD40 deficiency genes
38. Impaired B cell maturation in mice lacking Bruton's tyrosine kinase (Btk) and CD40
39. Functional analysis of peripheral blood B cells in patients with X-linked agammaglobulinemia
40. Bruton's tyrosine kinase links the B cell receptor to nuclear factor κB activation